Opioid-neuroleptic interaction in brainstem self-stimulation
- PMID: 2702479
- DOI: 10.1016/0006-8993(89)91401-7
Opioid-neuroleptic interaction in brainstem self-stimulation
Abstract
Injection of morphine into the ventral tegmental area (but not dorsal to it) induced a dose-dependent decrease in the frequency threshold for midline metencephalic brain stimulation reward. Facilitating doses of ventral tegmental morphine also reversed, in 4 of 6 animals, the threshold-increasing effects of pimozide (0.35 mg/kg, i.p.). This reversal was itself reversed by naloxone (2 mg/kg, i.p.), suggesting a direct action of morphine at ventral tegmental opiate receptors. These data fit with electrophysiological evidence that ventral tegmental morphine stimulates or disinhibits dopamine impulse flow, which would result in increased synaptic dopamine concentrations and decreased synaptic pimozide effectiveness. In the remaining two animals, the combined neuroleptic-opiate treatment resulted in a complete cessation of responding that was not reversed by a 5-fold increase in stimulation frequency. This finding suggested a complete inactivation of the reward mechanism, which might be expected from the interaction of high doses of two drugs that are each known to be capable of producing depolarization inactivation of dopaminergic neurons. These data confirm that brainstem self-stimulation, like medial forebrain bundle self-stimulation, depends critically on the function of the mesocorticolimbic dopamine system.
Similar articles
-
Behavioral evidence for midbrain dopamine depolarization inactivation.Brain Res. 1989 Jan 16;477(1-2):152-6. doi: 10.1016/0006-8993(89)91402-9. Brain Res. 1989. PMID: 2702480
-
Nicotine and brain-stimulation reward: interactions with morphine, amphetamine and pimozide.Pharmacol Biochem Behav. 1993 Oct;46(2):453-7. doi: 10.1016/0091-3057(93)90378-7. Pharmacol Biochem Behav. 1993. PMID: 8265701
-
Long-term changes in self-stimulation threshold by repeated morphine and naloxone treatment.Life Sci. 1985 Jul 15;37(2):169-76. doi: 10.1016/0024-3205(85)90420-5. Life Sci. 1985. PMID: 2989642
-
Effects of morphine and naloxone on thresholds of ventral tegmental electrical self-stimulation.Naunyn Schmiedebergs Arch Pharmacol. 1985 Aug;330(2):84-92. doi: 10.1007/BF00499899. Naunyn Schmiedebergs Arch Pharmacol. 1985. PMID: 4047179
-
Neuroleptic attenuation of intracranial self-stimulation: reward or performance deficits?Life Sci. 1978 Feb;22(7):535-42. doi: 10.1016/0024-3205(78)90331-4. Life Sci. 1978. PMID: 342858 Review. No abstract available.
Cited by
-
Different contributions of dopamine D1 and D2 receptor activity to alcohol potentiation of brain stimulation reward in C57BL/6J and DBA/2J mice.J Pharmacol Exp Ther. 2014 Aug;350(2):322-9. doi: 10.1124/jpet.114.216135. Epub 2014 Jun 10. J Pharmacol Exp Ther. 2014. PMID: 24917543 Free PMC article.
-
Intracranial self-stimulation in FAST and SLOW mice: effects of alcohol and cocaine.Psychopharmacology (Berl). 2012 Apr;220(4):719-30. doi: 10.1007/s00213-011-2523-x. Epub 2011 Oct 7. Psychopharmacology (Berl). 2012. PMID: 21983918 Free PMC article.
-
The kappa opioid receptor agonist U50,488H did not affect brain-stimulation reward while it elicited conditioned place aversion in mice.BMC Res Notes. 2020 Aug 14;13(1):384. doi: 10.1186/s13104-020-05227-7. BMC Res Notes. 2020. PMID: 32799930 Free PMC article.
-
CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat.Psychopharmacology (Berl). 2005 May;179(2):498-508. doi: 10.1007/s00213-004-2050-0. Epub 2004 Nov 18. Psychopharmacology (Berl). 2005. PMID: 15821959
-
Opposite modulation of brain stimulation reward by NMDA and AMPA receptors in the ventral tegmental area.Front Syst Neurosci. 2013 Oct 3;7:57. doi: 10.3389/fnsys.2013.00057. eCollection 2013. Front Syst Neurosci. 2013. PMID: 24106463 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources